At the last check on Monday, Cardinal Health Inc.’s (NYSE:CAH) stock was down -$2.52, moving down -2.69 percent to $91.25. The average number of shares traded per day over the past five days has been 2,019,060 shares. 3 times new highs have been achieved over the past 5 days, with a -$0.44 fall in that time frame. In the last twenty days, the average volume was 1,854,720, while in the previous 50 days, it was 2,338,918.
Since last month, CAH stock retreated -3.18%. Shares of the company fell to $90.92 on 07/31/23, the lowest level in the past month. A 52-week high of $95.10 was reached on 06/30/23 after having rallying from a 52-week low of $60.00. Since the beginning of this year, CAH’s stock price has risen by 18.71% or $14.38, and marked a new high 28 times. However, the stock has declined by -4.05% since its 52-week high.
CAH stock investors should be aware that Cardinal Health Inc. (CAH) stock had its last reported insider trading activity 263 days ago on Nov 15. Brennan Michelle, the Director of the company, purchased of 200 shares for $74.72 on Nov 15. It resulted in a $14,944 investment by the insider. Brennan Michelle added 200 shares at an average price of $76.30 on Nov 14. The insider now owns 3,124 shares following the transaction. On Nov 10, Director Brennan Michelle bought 150 shares at $79.74 apiece. The transaction was valued at $11,961.
Valuation Metrics
Right now, Cardinal Health Inc. (CAH) has a P/E ratio of about 52.20. The stock’s beta is 0.79.
The latest dividend of $0.5006 per share was paid out, which is 0.99% more than last year’s $0.4957. On Thursday May 11 2023, a $0.0049 dividend increase was announced.
Financial Health
In the three months ended March 30, Cardinal Health Inc.’s quick ratio stood at 0.50, while its current ratio was 1.00, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 3.40% percent. In the year ended March 30, EBITDA margin amounted to 1.32%, whereas operating margins totaled 0.30%. Based on annual data, CAH earned $6.54 billion in gross profit and brought in $181.36 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -16.70%. Return on equity (ROE) for the past 12 months was -26.80%.
In Cardinal Health Inc.’s quarter-end financial report for March 30, it reported total debt of $4.71 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. CAH’s revenue rose 11.19% to $51.47 billion during the quarter, while net income inched up to $50.49 billion. While analysts expected Cardinal Health Inc. to report $1.49 quarterly earnings, the actual figure was $1.74 per share, beating the consensus estimate by 16.80%. During the quarter, the company generated $747.0 million in EBITDA. The liabilities of Cardinal Health Inc. were 45.59 billion at the end of its most recent quarter ended March 30, and its total debt was $4.73 billion. The value of shareholders’ equity is $254.6 million.
Technical Picture
This quick technical analysis looks at Cardinal Health Inc.’s (CAH) price momentum. With a historical volatility rate of 19.47%, the RSI 9-day stood at 40.74% on 04 August.
With respect to its five-day moving average, the current Cardinal Health Inc. price is down by -0.48% percent or -$0.44. At present, CAH shares trade -2.89% below its 20-day simple moving average and +30.17% percent above its 100-day simple moving average. However, the stock is currently trading approximately +7.62% above its SMA50 and +33.76% above its SMA200.
Stochastic coefficient K was 47.68% and Stochastic coefficient D was 43.17%, while ATR was 1.44. Given the Stochastic reading of 8.82% for the 14-day period, the RSI (14) reading has been calculated as 45.53%. As of today, the MACD Oscillator reading stands at 0.33, while the 14-day reading stands at 0.06.
Analyst Ratings
Cardinal Health Inc. downgraded its rating on Cardinal Health Inc. (NYSE: CAH) to an In-line in a note to investors on July 10, 2023. The analysts firm previously had an Outperform rating on the stock.Cardinal Health Inc. (CAH) has been rated Hold by analysts. According to 0 brokerage firms, CAH is a sell, and 12 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 1 analyst rate Cardinal Health Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $93.50, the current consensus forecast for the stock is $78.00 – $107.00. Based on these forecasts, analysts predict Cardinal Health Inc. (CAH) will achieve an average price target of $94.79.
